MEI Pharma [thank you Novogen] in the US have partnered up with the Swiss Helsinn Group which means a trade-off has been made between potential royalty stream and making immediate finance available for advancing clinical trials; at the moment both parties are happy with the arrangement.
Something that the current version of Novogen could consider?
https://www.helsinn.com/our-business/partnerships/current-partnership/
- Forums
- ASX - By Stock
- KZA
- Ann: GDC 0084 progress update
Ann: GDC 0084 progress update, page-13
-
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)